advertisement
Oncology and Hematology
1926
177-192 of 790
- MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
1.00 program credit
Benjamin Levy, MD
Melin Khandekar, MD, PhD
- MinuteCE®
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
1.00 program creditBenjamin Levy, MD
Melin Khandekar, MD, PhD
Barbara O'Brien, MD
Nadia Harbeck, MD, PhD
Benjamin Levy, MD
Barbara O'Brien, MD
- MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
1.00 program creditBarbara O'Brien, MD
Nadia Harbeck, MD, PhD
Barbara O'Brien, MD
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Nadia Harbeck, MD, PhD
Brian P. McDonough, MD, FAAFP
Madison Conces, MD
Midhun Malla, MD
Raghava Reddy Induru, MD
Raghava Reddy Induru, MD
Brian P. McDonough, MD, FAAFP
Alicia Lieberman, MD, MS
Matt Birnholz, MD
